NCT02338544View on ClinicalTrials.gov

Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne

CompletedOBSERVATIONAL
Enrollment

1,388

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Acne Vulgaris
Interventions
DRUG

0.1% Adapalene / 2.5% Benzoyl peroxide

Epiduo® gel containing 0.1% adapalene + 2.5% benzoyl peroxide dispensed from a pump.

All Listed Sponsors
lead

Galderma Laboratorium GmbH

INDUSTRY

NCT02338544 - Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne | Biotech Hunter | Biotech Hunter